Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver Disease-Reference-Cited by-同舟云学术

Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver Disease

Published:2017-01-03 Issue:3 Volume:166 Page:191
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Crowley Matthew J.¹,Diamantidis Clarissa J.¹,McDuffie Jennifer R.¹,Cameron C. Blake¹,Stanifer John W.¹,Mock Clare K.¹,Wang Xianwei¹,Tang Shuang¹,Nagi Avishek¹,Kosinski Andrzej S.¹,Williams John W.¹

Affiliation:

1. From Durham Veterans Affairs Medical Center and Duke University School of Medicine, Durham, North Carolina.

Funder

U.S. Department of Veterans Affairs

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Cited by 224 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A mechanistic analysis of metformin's biphasic effects on lifespan and healthspan in C. elegans: Elixir in youth, poison in elder;Mechanisms of Ageing and Development;2024-10

2. Clinical outcomes in type 2 diabetes patients with chronic heart failure treated with metformin: a meta-analysis;Endocrine;2024-09-15

3. ONOO–-activatable and LD-traced NIR fluorescent probe for mechanism study and early diagnosis of NAFLD and diabetes induced liver injury;Sensors and Actuators B: Chemical;2024-08

4. A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes – 2nd edition (English version);Journal of Diabetes Investigation;2024-07-11

5. Optimizing metformin therapy in practice: Tailoring therapy in specific patient groups to improve tolerability, efficacy and outcomes;Diabetes, Obesity and Metabolism;2024-07-10